Effect of L carnitine on Coronary Artery Disease Patients Outcome
Not Applicable
- Conditions
- Coronary Artery Disease(CAD).Ischaemic heart diseasesI20-I25
- Registration Number
- IRCT2016060528260N1
- Lead Sponsor
- Vice Chancellor for research of Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients having at least 50% stenosis of one major coronary artery or receiving percutaneous transluminal coronary angioplasty (PTCA).
Exclusion criteria: The patients with diabetes, liver, or renal diseases will be excluded. The patients under medications therapy, such as acenocoumarol, thyroid hormone, and warfarin, and those currently receiving vitamin supplements will also be excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hs-CRP. Timepoint: before and after. Method of measurement: ELISA assay.;Myeloproxidase(MPO). Timepoint: before and after. Method of measurement: ELISA assay.;Nitrityrosine(NT). Timepoint: before and after. Method of measurement: ELISA assay.;Total antioxidant capacity(TAC). Timepoint: before and after. Method of measurement: Colorimetric assay.;Body composition. Timepoint: At first and the end of sixth and twelfth weeks of the study. Method of measurement: body Analyzers Jown Plus (Avis 333).
- Secondary Outcome Measures
Name Time Method Evalution of patients diet. Timepoint: At first and the end of sixth and twelfth weeks. Method of measurement: 24 hour recall questionare.;The level of physical activity. Timepoint: at first and the end of sixth and twelfth weeks of study. Method of measurement: IPAQ questionare.;Blood pressure. Timepoint: at first and the end of study. Method of measurement: By mercury sphygmomanometer.